Key facts
- This page summarizes Michael D. Milligan's Form 4 filing for Conformis Inc.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 May 2022, 14:13.
Michael D. Milligan - 24 May 2022 Form 4 Insider Report for Conformis Inc
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 24 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 May 2022, 14:13:36 UTC
- Prior SEC filing
- 28 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Denise E. Pedulla, Attorney-in-Fact for Michael Milligan
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael D. Milligan filed Form 4 for Conformis Inc on 26 May 2022.
Change
- Previous filing in this sequence was filed on 28 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CFMS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +130,870
- Change %
- +107%
- Price
- $0.000000
- Shares after
- 253,093
- Date
- 24 May 2022
- Ownership
- Direct
- Footnotes
- F1
CFMS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 937,500
- Date
- 24 May 2022
- Ownership
- See footnote.
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the number of RSAs granted to the Reporting Person pursuant to Conformis' 2015 Stock Incentive Plan. The shares will vest 100% on the one year anniversary of the grant date.
Footnote F2
The securities are directly held by NewtrAx LLC, which is indirectly controlled by Lexa International Corporation. The Reporting Person is affiliated with NewtrAx LLC and disclaims beneficial ownership of all shares except to the extent of his pecuniary interest therein.